Evidence map›Paper›PMID 42493462›Full record

ArticleBeijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences2026

[Visceral leishmaniasis with suspected autoimmune disease: A report of 2 cases].

Fan Sun, Maomao Chen, Aixin Huo, Wen Zhang, Zhuo Li, Lan Cheng, Yuhong Liu

Abstract readCase ReportsEnglish Abstract
In one paragraph

Article in Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fan SunDepartment of Rheumatology and Immunology, Yan'an University Affiliated Hospital, Yan'an 716000, Shaanxi, China.
Maomao ChenDepartment of Rheumatology and Immunology, Yan'an University Affiliated Hospital, Yan'an 716000, Shaanxi, China.
Aixin HuoDepartment of Rheumatology and Immunology, Yan'an University Affiliated Hospital, Yan'an 716000, Shaanxi, China.
Wen ZhangDepartment of Hematology, Yan'an University Affiliated Hospital, Yan'an 716000, Shaanxi, China.
Zhuo LiDepartment of Rheumatology and Immunology, Yan'an University Affiliated Hospital, Yan'an 716000, Shaanxi, China.
Lan ChengDepartment of Rheumatology and Immunology, Yan'an University Affiliated Hospital, Yan'an 716000, Shaanxi, China.
Yuhong LiuDepartment of Rheumatology and Immunology, Yan'an University Affiliated Hospital, Yan'an 716000, Shaanxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Visceral leishmaniasis (VL) is a rare parasitic infection characterized by distinctive features, including the overproduction of various autoantibodies by B cells, which may mimic manifestations and antibody profiles associated with autoimmune diseases. In this report, we presented two patients diagnosed with visceral leishmaniasis who were initially suspected of having an autoimmune disease. We discussed the similarities and differences between visceral leishmaniasis and autoimmune diseases based on clinical presentation, physical examination findings, laboratory tests, diagnosis, and treatment. Case 1 involved a 69-year-old female patient who was admitted to the hospital due to irregular fever. Physical examination revealed splenomegaly. Laboratory investigations indicated pancytopenia along with an abnormal autoantibody profile. The initial bone marrow aspirate demonstrated: Proliferative changes in the bone marrow, and abnormal lymphocytes in peripheral blood accounting for approximately 6%. Auto-immune disease was initially considered, and hormone therapy did not respond well. Further screening for immunological disorders, infections, tumors, and other related conditions was conducted. A second bone marrow aspirate was performed actively which revealed Leishman-Donovan body. Subsequent nuc-leic acid detection of pathogenic microorganisms confirmed the presence of Leishmania through real-time fluorescence PCR analysis; thus, confirming a diagnosis of visceral leishmaniasis. Case 2 involved a 41-year-old male patient who presented with fever and abdominal distension. Similar to Case 1, physical examination also showed splenomegaly alongside an abnormal autoantibody profile. During treatment, he tested positive for Leishmania infection and was ultimately diagnosed with visceral leishmaniasis complicated by hemophagocytic syndrome. The symptoms observed in the two patients included recurrent fever, anorexia, and splenomegaly. To further investigate the cause of pancytopenia and to rule out factors such as surgery, infection, tumors, and other related conditions, an abnormal antinuclear antibody profile was assessed. The initial misdiagnosis pointed towards autoimmune diseases; however, during treatment, visceral leishmaniasis infection was identified, leading to a final diagnosis of visceral leishmaniasis. The gold standard for diagnosing visceral leishmaniasis involves detecting Leishmania bodies through aspiration of bone marrow, lymph nodes, or spleen. The positive rate for bone marrow puncture is approximately 80% to 90%. However, clinical practice may encounter missed detections due to limitations associated with the puncture site. This underscores the necessity for secondary punctures when warranted. Addi-tionally, patients presenting with splenomegaly accompanied by trilineage cytopenia often seek care from Department of Hematology or Department of Rheumatology and Immunology rather than Department of Infection. This tendency can contribute to both misdiagnosis and missed diagnoses. It is hoped that this case report will offer valuable insights for clinicians in enhancing their diagnostic capabilities and improving the clinical detection rates of visceral leishmaniasis.

Indexed as

Autoimmune DiseasesLeishmaniasis, VisceralAdultAgedDiagnosis, DifferentialFemaleHumansMaleAutoimmune diseasesHemophagocytic lymphohistiocytosisVisceral leishmaniasis

Identifiers

PMID42493462
PMCPMC13402086

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.